Table of Contents Table of Contents
Previous Page  558 / 1851 Next Page
Information
Show Menu
Previous Page 558 / 1851 Next Page
Page Background

Nivolumab vs. docetaxel for advanced NSCLC

Brahmer et al NEJM 2015